Polyamine Inhibitor SAM486A Augments Cytarabine Cytotoxicity in Methylthioadenosine Phosphorylase-deficient Leukemia Cells

Anticancer Res. 2024 Mar;44(3):981-991. doi: 10.21873/anticanres.16893.

Abstract

Background/aim: Methionine metabolism contributes to supplying sulfur-containing amino acids, controlling the methyl group transfer reaction, and producing polyamines in cancer cells. Polyamines play important roles in various cellular functions. Methylthioadenosine phosphorylase (MTAP), the key enzyme of the methionine salvage pathway, is reported to be deficient in 15-62% of cases of hematological malignancies. MTAP-deficient cancer cells accumulate polyamines, resulting in enhanced cell proliferation. The aim of this study was to investigate the combined effects of the polyamine synthesis inhibitor SAM486A and the anticancer antimetabolite cytarabine in MTAP-deficient leukemic cells in vitro.

Materials and methods: The leukemia cell line U937 and the subline, U937/MTAP(-), in which MTAP was knocked down by shRNA, were used. The experiments were performed in media supplemented with 20% methionine (low methionine), which was the minimum concentration for maintaining cellular viability.

Results: The knockdown efficiency test confirmed a 70% suppression of the expression of the MTAP gene in U937/MTAP(-) cells. Even in the media with low methionine, the intracellular methionine concentration was not reduced in U937/MTAP(-) cells, suggesting that the minimum supply of methionine was sufficient to maintain intracellular levels of methionine. Both U937/MTAP(+) and U937/MTAP(-) cells were comparably sensitive to anticancer drugs (cytarabine, methotrexate, clofarabine and 6-thioguanine). The combination of SAM486A and cytarabine was demonstrated to have synergistic cytotoxicity in U937/MTAP(-) cells with regard to cell growth inhibition and apoptosis induction, but not in U937/MTAP(+) cells. Mechanistically, SAM486A altered the intracellular polyamine concentrations and reduced the antiapoptotic proteins.

Conclusion: Methionine metabolism and polyamine synthesis can be attractive therapeutic targets in leukemia.

Keywords: Acute leukemia; MTAP; SAM486A; cytarabine (ara-C); methionine; methylthioadenosine phosphorylase; polyamines; sardomozide dihydrochloride.

MeSH terms

  • Amidines*
  • Antineoplastic Agents*
  • Cytarabine / pharmacology
  • Humans
  • Indans*
  • Leukemia* / drug therapy
  • Methionine / metabolism
  • Methionine / pharmacology
  • Polyamines
  • Purine-Nucleoside Phosphorylase / genetics
  • Purine-Nucleoside Phosphorylase / metabolism

Substances

  • 5'-methylthioadenosine phosphorylase
  • 4-amidinoindan-1-one 2'-amidinohydrazone
  • Cytarabine
  • Antineoplastic Agents
  • Purine-Nucleoside Phosphorylase
  • Polyamines
  • Methionine
  • Amidines
  • Indans